封面
市場調查報告書
商品編碼
1721505

蝦紅素市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Astaxanthin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 263 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球蝦紅素市場價值為 9.981 億美元,預計到 2034 年將以 8.8% 的複合年成長率成長,達到 21.5 億美元。蝦紅素是一種來自天然和合成來源的強效抗氧化劑,隨著消費者對健康和保健意識的不斷增強,它在各個行業中迅速發展。隨著消費者越來越青睞天然、清潔標籤的產品,蝦紅素因其廣泛的健康益處而成為首選成分。隨著慢性生活方式疾病在年輕族群中變得越來越普遍,對預防性保健解決方案的需求也大幅增加。蝦紅素因其減少氧化壓力和發炎的能力而聞名,越來越被認為是膳食補充劑和護膚配方中的關鍵成分。

蝦紅素市場 - IMG1

隨著消費者尋求支持整體健康(包括皮膚、眼睛和心血管健康)的多功能成分,市場正在經歷重大轉變。健康習慣和功能性產品的日益普及,尤其是在千禧世代和 Z 世代中,推動了對天然蝦紅素的需求。製造商也注意到了這一趨勢,透過提供永續和環保的產品,這與人們對清潔美容、植物營養和環保生活的日益重視相一致。隨著研究不斷發現蝦紅素在醫藥、功能性食品甚至寵物營養方面的新應用,未來幾年市場將實現強勁、持續的成長。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 9.981億美元
預測值 21.5億美元
複合年成長率 8.8%

市場分為合成來源和天然來源,其中天然蝦紅素佔據主導地位,到 2024 年市場規模達 6.332 億美元。這種主導地位反映了消費者對植物性和天然成分的需求不斷成長,因為注重健康的買家會避免合成添加劑。對清潔標籤產品的偏好提高了天然蝦紅素在補充劑、個人護理產品和強化食品中的使用。

蝦紅素廣泛應用於膳食補充劑、藥品、個人護理、食品和飲料以及動物飼料。光是膳食補充劑領域在 2024 年的估值就達到 3.156 億美元,預計在 2025-2034 年期間的複合年成長率將達到 9.2%。這種成長源於消費者對富含抗氧化劑的補充劑的興趣日益濃厚,這些補充劑可以促進免疫支持、皮膚健康和眼睛功能。在個人護理中,蝦紅素因其被證實具有中和自由基和增強皮膚彈性的能力而被廣泛應用於抗衰老護膚品中。

2024 年,美國蝦紅素市場規模達到 7,740 萬美元。隨著消費者對天然抗氧化劑及其健康益處的認知不斷提高,美國不斷擴大的營養保健品、護膚品和功能性食品產業繼續推動需求。

全球蝦紅素市場的主要參與者包括巴斯夫、Cardax、Algaecan Biotech、Cyanotech Corporation、富士化學工業有限公司、Divis Laboratories Limited、INNOBIO Limited、Lycored、昆明生物有限公司和Piveg, Inc. 這些公司正在積極投資高品質、永續生產和戰略合作夥伴關係,為廣泛的行業提供創新、研發的蝦紅素解決方案。

目錄

第1章:方法論與範圍

第2章:執行摘要

第3章:行業洞察

  • 產業生態系統分析
    • 影響價值鏈的因素
    • 利潤率分析
    • 中斷
    • 未來展望
    • 製造商
    • 經銷商
  • 供應商格局
  • 利潤率分析
  • 重要新聞和舉措
  • 監管格局
  • 衝擊力
    • 成長動力
      • 消費者對蝦紅素護膚品和藥品的需求不斷成長
      • 蝦紅素在全球烹飪應用中越來越受歡迎
      • 生態永續實踐和清潔標籤趨勢的成長
    • 產業陷阱與挑戰
      • 蝦紅素產品製造的監管障礙
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析

第4章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第5章:市場估計與預測:按來源,2021 - 2034 年

  • 主要趨勢
  • 合成的
  • 自然的

第6章:市場估計與預測:按應用,2021 - 2034 年

  • 主要趨勢
  • 膳食補充劑
  • 個人護理
  • 製藥
  • 食品和飲料
    • 功能性食品和飲料
    • 其他
  • 動物飼料
    • 水產養殖
      • 鮭魚
      • 鱒魚
      • 其他
    • 家畜
    • 寵物

第7章:市場估計與預測:按地區,2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第8章:公司簡介

  • Algaecan Biotech
  • BASF
  • Cardax
  • Cyanotech Corporation
  • Divis Laboratories Limited
  • Fuji Chemical Industries Company Limited
  • INNOBIO Limited
  • Kunming Biogenic Company Limited
  • Lycored
  • Piveg, Inc.
簡介目錄
Product Code: 202

The Global Astaxanthin Market was valued at USD 998.1 million in 2024 and is estimated to grow at a CAGR of 8.8% to reach USD 2.15 billion by 2034. Astaxanthin, a powerful antioxidant derived from both natural and synthetic sources, is rapidly gaining momentum across industries due to growing consumer awareness around health and wellness. As consumers shift their preferences toward natural, clean-label products, astaxanthin has emerged as a go-to ingredient for its wide-ranging health benefits. With chronic lifestyle diseases becoming more common among younger populations, demand for preventive health solutions has soared. Astaxanthin, known for its ability to reduce oxidative stress and inflammation, is increasingly recognized as a critical ingredient in both dietary supplements and skincare formulations.

Astaxanthin Market - IMG1

The market is witnessing a major shift as consumers seek multi-functional ingredients that support holistic health, including skin, eye, and cardiovascular wellness. The rising popularity of wellness routines and functional products, especially among millennials and Gen Z, is propelling the demand for natural astaxanthin. Manufacturers are also taking notice of this trend by offering sustainable and eco-friendly products, which align with the growing emphasis on clean beauty, plant-based nutrition, and environmentally conscious living. As research continues to uncover new applications of astaxanthin in pharmaceuticals, functional foods, and even pet nutrition, the market is poised for strong, sustained growth in the coming years.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$998.1 Million
Forecast Value$2.15 Billion
CAGR8.8%

The market is segmented into synthetic and natural sources, with natural astaxanthin accounting for a dominant share of USD 633.2 million in 2024. This dominance reflects the increasing consumer demand for plant-based and naturally derived ingredients, as health-conscious buyers steer clear of synthetic additives. The preference for clean-label products has elevated the use of natural astaxanthin across supplements, personal care products, and fortified foods.

Astaxanthin finds broad application in dietary supplements, pharmaceuticals, personal care, food and beverages, and animal feed. The dietary supplements segment alone recorded a valuation of USD 315.6 million in 2024 and is set to grow at a 9.2% CAGR during 2025-2034. This growth stems from rising consumer interest in antioxidant-rich supplements that promote immune support, skin health, and eye function. In personal care, astaxanthin is widely adopted in anti-aging skincare due to its proven ability to neutralize free radicals and enhance skin elasticity.

The United States Astaxanthin Market reached USD 77.4 million in 2024. The country's expanding nutraceutical, skincare, and functional food sectors continue to drive demand, supported by growing consumer awareness about natural antioxidants and their health benefits.

Key players in the global astaxanthin market include BASF, Cardax, Algaecan Biotech, Cyanotech Corporation, Fuji Chemical Industries Company Limited, Divis Laboratories Limited, INNOBIO Limited, Lycored, Kunming Biogenic Company Limited, and Piveg, Inc. These companies are actively investing in R&D, sustainable production, and strategic partnerships to deliver innovative, high-quality astaxanthin solutions across a broad spectrum of industries.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news and initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Rising consumer demand for astaxanthin-based skincare and pharmaceuticals
      • 3.6.1.2 Increasing popularity of astaxanthins in culinary applications globally
      • 3.6.1.3 Growth in eco-sustainable practices and clean-label trends
    • 3.6.2 Industry pitfalls and challenges
      • 3.6.2.1 Regulatory hurdles in astaxanthin product manufacturing
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2034 (USD Million) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Synthetic
  • 5.3 Natural

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 (USD Million) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Dietary supplement
  • 6.3 Personal care
  • 6.4 Pharmaceuticals
  • 6.5 Food & beverages
    • 6.5.1 Functional food & beverages
    • 6.5.2 Others
  • 6.6 Animal feed
    • 6.6.1 Aquaculture
      • 6.6.1.1 Salmon
      • 6.6.1.2 Trout
      • 6.6.1.3 Shrimp
      • 6.6.1.4 Others
    • 6.6.2 Livestock
    • 6.6.3 Pets

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Million) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Algaecan Biotech
  • 8.2 BASF
  • 8.3 Cardax
  • 8.4 Cyanotech Corporation
  • 8.5 Divis Laboratories Limited
  • 8.6 Fuji Chemical Industries Company Limited
  • 8.7 INNOBIO Limited
  • 8.8 Kunming Biogenic Company Limited
  • 8.9 Lycored
  • 8.10 Piveg, Inc.